Urinalysis Market worth $6.8 billion by 2029

As per the recently published report by MarketsandMarkets?, The report "Urinalysis Market by Product (Consumables (Pregnancy & Fertility Kits, Dipsticks, Disposable, Reagents), Instruments (Automated, Semi-automated, PoC Analyzers)), Test Type (Biochemical, Sediment), Application (UTI, Diabetes) - Global Forecast to 2029", is valued at an estimated USD 4.3 billion in 2024 and is projected to reach USD 6.8 billion by 2029 at a CAGR of 9.6% during the forecast period.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=153479294 ?

Browse

• 483? ? ?Market Data Tables
• 49? ? ? ?Figures
• 390? ??Pages and in-depth TOC on?" Urinalysis Market - Global Forecast to 2029”

Some of the prominent key players are:

• Siemens Healthineers AG (Germany),
• F. Hoffmann-La Roche Ltd. (Switzerland),
• Cardinal Health, Inc. (US),
• Abbott Laboratories (US),
• Danaher Corporation (US), and many more......

Mergers & acquisitions, investments & expansions, partnerships & collaborations, and new product developments are some of the major strategies adopted by these key players to enhance their positions in the Urinalysis Market.

• Based on product, the urinalysis market is segmented into consumables and instruments. The consumables segment dominated the urinalysis market in 2023 due to its recurrent purchase requirement. Consumables such as kits, test strips, reagents, and disposables are used in every urinalysis test, making their demand continuous and high.
• Based on test type, the urinalysis market is segmented into biochemical tests, sediment urinalysis, and pregnancy & fertility tests. In 2023, largest share of the urinalysis market was held by the pregnancy & fertility tests segment. Technological advancements have enhanced the accuracy, ease of use, and speed of these tests, making them more reliable and user-friendly.
• On the basis of application, the urinalysis market is segmented into disease screening and pregnancy & fertility testing. The disease screening segment accounted for the largest share of the urinalysis market in 2023. Urinalysis plays a crucial role in the early detection and monitoring of various conditions such as diabetes, kidney disease, urinary tract infections, and liver disease.?
• The market for urinalysis has been divided into six key geographical regions, namely North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries. In 2023, North America held the predominant portion of the urinalysis market. The region boasts a well-developed healthcare infrastructure, including advanced diagnostic facilities, and a skilled workforce.

This market has grown significantly over the last few years due to the increasing adoption of PoC testing products in home care and hospitals. The convenience of these tools has driven their adoption, particularly considering the rising prevalence of chronic and lifestyle diseases, technological advancements in PoC testing products, growing patient awareness of PoC testing, shortage of technicians to conduct conventional lab tests, and the rising number of Clinical Laboratory Improvement Amendments (CLIA) approvals for PoC tests. Point-of-care testing (POCT) in urine analysis positively impacts the operational efficiency and care of patients with CKD.

?